Document ID: chunk:federal_register_of_legislation:F2020L00211:reg:9:p2
Version: federal_register_of_legislation:F2020L00211
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6318–9229

Schedule 1 - Dictionary.
(13)      being treated with a drug which is associated in the individual with:
(a)          the development of the symptoms or signs of acute pancreatitis within two months of commencing drug therapy; and
(b)          the cessation of the symptoms or signs of acute pancreatitis following the discontinuation of drug therapy; and
(c)          an absence of clinical or laboratory evidence of acute pancreatitis prior to beginning drug therapy; and
(d)          where treatment with the drug continued for at least the three days before the clinical onset of acute pancreatitis;
(14)      having diabetes mellitus at the time of the clinical onset of acute pancreatitis;
(15)      having hypertriglyceridaemia resulting in triglyceride levels above 11.3 millimoles per litre (or 1 000 milligrams per decilitre) at the time of the clinical onset of acute pancreatitis;
(16)      having hypercalcaemia at the time of the clinical onset of acute pancreatitis;
(17)      having a disease from the specified list of diseases at the time of the clinical onset of acute pancreatitis;
Note: specified list of diseases is defined in the Schedule 1 - Dictionary.
(18)      having a disorder resulting in disseminated intravascular coagulation and/or profound systemic hypotension with pancreatic acinar damage within the seven days before the clinical onset of acute pancreatitis;
(19)      having an acute infection with an organism at the time of the clinical onset of acute pancreatitis;
Note: acute infection with an organism is defined in the Schedule 1 - Dictionary.
(20)      having infection with human immunodeficiency virus at the time of the clinical onset of acute pancreatitis;
(21)      having an infestation from the specified list of infestations at the time of the clinical onset of acute pancreatitis;
Note: specified list of infestations is defined in the Schedule 1 - Dictionary.
(22)      being envenomated by a snake or scorpion from the specified list within the seven days before the clinical onset of acute pancreatitis;
Note: snake or scorpion from the specified list is defined in the Schedule 1 - Dictionary.
(23)      having acute toxicity after oral ingestion of mushrooms containing alpha-amanitin within the seven days before the clinical onset of acute pancreatitis;
Note: alpha-amanitin is defined in the Schedule 1 - Dictionary.
(24)      ingesting an agent from the specified list of agents and experiencing acute toxicity within the seven days before the clinical onset of acute pancreatitis;
Note: specified list of agents is defined in the Schedule 1 - Dictionary.
(25)      for severe acute pancreatitis only, being obese at the time of the clinical onset of acute pancreatitis;
Note: being obese and severe acute pancreatitis are defined in the Schedule 1 – Dictionary.
(26)      inability to obtain appropriate clinical management for acute pancreatitis.